Researchers at the Scripps Research Institute in La Jolla, California have developed a ‘superactivated’ version of the popular cosmetic treatment toxin-botulinum neurotoxin, also known as Botox.

Dr. Kim Janda, the leader of the study reports that the team created a synthetic molecule that increases the strength of the toxin, making it as much as 14 times more potent and effective than the original Botox. 

Botox, which is commonly used for the treatment of migraine headaches, lazy eyes and extreme sweating, has been found to be highly effective at also relieving the signs of wrinkling.  In recent years, the use of Botox as a wrinkle treatment has grown exponentially. 

The paralyzing effects of the toxin are greatly increased in the new ‘superactivated’ version of Botox, making the dosage necessary for visible results significantly less. 

Scientists at the Scripps Research Institute in La Jolla believe that the benefits of their new discovery could be tremendously important for the field of cosmetic treatment.

In addition to the lower dosage benefit and therefore potentially lower cost of the improved treatment, the new Botox formula is anticipated to last longer than the original.

Lower doses of the treatment will also reduce the risk for immune system complications that can potentially be brought on by the toxin. 

Dr. Janda commented on the results of the study, “ We have developed a synthetic molecule that binds to the toxin and increases its normal function.  The discovery of small molecule activators may ultimately provide a valuable method for minimizing dosage, reducing resistance, and increasing its clinical efficacy.” 

For more information regarding Botox and other cosmetic treatments, you may wish to speak with a board certified plastic surgeon who can thoroughly address your questions and concerns.